Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Label Mixup: ROSUVASTATIN CALCIUM, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: IBUPROFEN, Tablet, 400 mg, NDC 67877029401, Pedigree: W002577, EXP: 6/3/2014; ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD21846_49, EXP: 5/1/2014.
| Distributed by / for | AidaPak Service, LLC |
| NDC | 00310075590 |
| Full product label | ROSUVASTATIN CALCIUM, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00310075590. |
| Recalling firm | Aidapak Services, LLC |
| Distribution | Repacked drugs were distributed in Arizona, California, Oregon, and Washington. |
| Quantity | 180 Tablets |
| Recall initiated | 2013-07-02 |
| Report date | 2014-01-29 |
| Recall completed | 2014-02-07 |
| Recall number | D-887-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Vancouver WA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗